TWLV vs. ENGN, DHHC, SBEA, NETD, ENPC, CDRO, IPXX, XPAX, KAII, and LGVC
Should you be buying Twelve Seas Investment Company II stock or one of its competitors? The main competitors of Twelve Seas Investment Company II include enGene (ENGN), DiamondHead (DHHC), SilverBox Engaged Merger Corp I (SBEA), Nabors Energy Transition Corp. II (NETD), Executive Network Partnering (ENPC), Codere Online Luxembourg (CDRO), Inflection Point Acquisition Corp. II (IPXX), Zalatoris II Acquisition (XPAX), Kismet Acquisition Two (KAII), and LAMF Global Ventures Corp. I (LGVC).
enGene (NASDAQ:ENGN) and Twelve Seas Investment Company II (NASDAQ:TWLV) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends, analyst recommendations and community ranking.
enGene received 7 more outperform votes than Twelve Seas Investment Company II when rated by MarketBeat users.
enGene currently has a consensus price target of $34.40, suggesting a potential upside of 173.67%. Given Twelve Seas Investment Company II's higher probable upside, research analysts clearly believe enGene is more favorable than Twelve Seas Investment Company II.
64.2% of enGene shares are owned by institutional investors. Comparatively, 7.9% of Twelve Seas Investment Company II shares are owned by institutional investors. 13.7% of enGene shares are owned by insiders. Comparatively, 79.8% of Twelve Seas Investment Company II shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, enGene had 37 more articles in the media than Twelve Seas Investment Company II. MarketBeat recorded 41 mentions for enGene and 4 mentions for Twelve Seas Investment Company II. enGene's average media sentiment score of 1.18 beat Twelve Seas Investment Company II's score of 0.05 indicating that Twelve Seas Investment Company II is being referred to more favorably in the news media.
enGene has a beta of -0.4, suggesting that its share price is 140% less volatile than the S&P 500. Comparatively, Twelve Seas Investment Company II has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500.
Twelve Seas Investment Company II's return on equity of 0.00% beat enGene's return on equity.
Summary
enGene beats Twelve Seas Investment Company II on 6 of the 11 factors compared between the two stocks.
Get Twelve Seas Investment Company II News Delivered to You Automatically
Sign up to receive the latest news and ratings for TWLV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TWLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Twelve Seas Investment Company II Competitors List
Related Companies and Tools
